In addition to joint product development, Xyall and Motic have established a reseller and support agreement to accelerate the delivery of these offerings into Chinese and Asian markets.
The strategic partnership with Motic adds digital pathology, workflow and scalable capabilities to the Xyall platform and the company expects to have its first table-top products ready for launch in autumn next year. In 2019, Xyall partnered with high-tech engineering company Sioux to bring high precision (medical) robotic solutions and machine learning expertise to their platform.
Tissue dissection remains a labor-intensive process at risk of error and cross contamination. “Xyall aims to transform the way laboratories carry this out, by delivering an automatic solution with greater accuracy, throughput and quality control,” explained Guido du Pree, Xyall’s CEO.
The combined expertise of our strategic partners creates a dynamic, conviction-led allianceGuido du Pree
The company is building a platform to support clinicians and lab managers with faster and more accurate tissue dissection solutions to support them in delivering precision diagnostics. An automated system also makes the most efficient use of existing staffing levels.
Alongside the hospital-based system, Xyall intends to launch an industrial, automated tissue dissection solution for high volume (commercial) molecular pathology laboratories. Using the same technology platform, the launch of this large-scale system is planned for spring 2021.
"We are delighted to join forces with Motic,” said Guido du Pree. “Their knowledge and experience in optics, imaging, pathology workflow, and strong market position in digital pathology, especially in Asia, is an enormous asset and will boost our development and commercialization. The combined expertise of our strategic partners creates a dynamic, conviction-led alliance - to create and drive forward our unique global solutions for both high volume and hospital-based molecular pathology laboratories.”
Richard Yeung, Motic’s CEO, added: “Motic is not only a trusted global provider of microscopy and digital whole slide imaging solutions, but also operates one of the largest tele-pathology consultation platforms in the world. By teaming up with Xyall and Sioux, we are confident that we have created the synergies needed to build another milestone in digital pathology industry.”
Current practice in tissue dissection involves the pathologist in pen-marking Regions of Interest (ROIs) on Hematoxylin & Eosin (H&E) stained slides. Using visual assessment, lab technicians then translate these ROIs into dissection slides, manually scraping the tissue and placing it in small containers. In view of the worldwide shortage of laboratory technicians, this puts pressure on clinical labs.